Physical and Engineering Sciences in Oncology

by: Michael Saunders

The National Science Foundation, otherwise referred to as NSF, is a United States Government agency that is primarily responsible for pursuing and ensuring fundamental research studies and education in all the non-medical fields of science and engineering.

The programs and activities of the NSF are administered in an effort to help them realize their mission, which is "to promote the progress of science; to advance the national health, prosperity, and welfare; to secure the national defense."

In keeping with this mission, the National Science Foundation, in close cooperation the National Cancer Institute, has recently developed the Physical and Engineering Sciences in Oncology Program wherein they intend to obtain a more thorough understanding of cancer disorders with the application of physical and engineering sciences.

The folks at NSF believe that the discovery of significant advances is greatly possible as a result of the consistent investments in inter- and multi-disciplinary research studies concerning the application of physical/engineering and life sciences and its impact on unraveling the cause and origin of cancer cell formation.

In addition, the NSF perceives that these advances will significantly contribute to the prevention, early detection, and efficient treatment of cancer disorders. Which is very much essential because cancer is one of the most fatal diseases in the world today.

The proposals that will be submitted to the NSF should include the following:

  (continued...)

Physical and Engineering Sciences in Oncology
  Page 2

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on community grants and health grants.

Additional Resources

category - Health Grants

Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program
In keeping with this mission, the National Institutes of Health has partnered with the Canadian Institutes of Health Research (CIHR), the National Heart, Lung, and Blood Institute (NHLBI), and the Institute of Circulatory and Respiratory Health (ICRH) to establish the Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program.

---

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
The National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.

---

Excellence in Hemoglobinopathies Research Award Program
The National Institutes of Health has formed a collaboration with the National Heart, Lung, and Blood Institute (NHLBI) in an effort to establish the Excellence in Hemoglobinopathies Research Award Program wherein both agencies have agreed to financially support the creation of studies that could potentially improve high-impact multi-disciplinary basic and translational research studies in the hemoglobinopathies.

---

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---